Two strengths of berberine ursodeoxycholate improved HbA1c compared with placebo in a phase II trial. The higher-dose group also had improvements in other metabolic and liver markers. The treatment ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that ...

Being diagnosed with type 2 diabetes at 35 can come as a shock, and it’s only natural to have doubts about medicines. So, ...

A new GLP-1 pill from Eli Lilly has shown positive results in clinical trials. New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 ...

Intermittent fasting has gained popularity among individuals who want to lose weight. While this approach has shown promising results, it may not be the best eating plan for everyone. When discussing ...

Of the estimated 38 million Americans diagnosed with diabetes, an overwhelming majority has Type 2. Diabetes is a chronic health condition that affects how the body turns food into energy. It develops ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...